Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers(Fed)

NCT03927170 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

COMBINATION_PRODUCT: Janumet XR tablet 100/1000 mg
COMBINATION_PRODUCT: GLH1SM tablet 100/1000 mg

Sponsor

GL Pharm Tech Corporation